Real-world evidence paper highlighting the impact of changes to tuberculosis diagnosis and treatment in China CONTEXT: China has managed to reduce the incidence rate of tuberculosis (TB) over the last Continue Reading
Medidata’s Acorn AI Synthetic Control Arm (SCA) awarded Best AI-based Solution for Healthcare. CONTEXT: Medidata’s Acorn AI Synthetic Control Arm (SCA) takes Best AI-based Solution for Healthcare at this years Continue Reading
Two Real-World Evidence studies show effectiveness of FDA authorised COVID vaccines CONTEXT: The publication of two peer-reviewed studies from nference (yes that is their name – not a typo) in Continue Reading
Peer reviewed publication of a retrospective real-world evidence study in Type 2 diabetes CONTEXT: A retrospective chart review of type 2 diabetes patients in India receiving either Metformin alone or Continue Reading
Tandem Diabetes Care presentations positive Real-World improvements from it’s insulin pump. CONTEXT: Tandem Diabetes Care announces a series of presentations at the 81st Scientific Sessions of the American Diabetes Association. Continue Reading
The Indian Council of Medical Research (ICMR) launches national Real-World study to assess COVID vaccine. CONTEXT: A report from the Times of India on the newly launched Indian Council of Continue Reading
Leading medical device company presents real-world use of InPen™ on glycemic and insulin design outcomes. CONTEXT: Amongst the 7 data presentations at this year’s American Diabetes Association meeting will be findings Continue Reading
A new real-world research study evaluates the safety profile and discontinuation rates of Cosentyx (secukinumab) in patients with axial spondyloarthritis (AxSpA) and psoriatic arthritis (PsA) CONTEXT: This report published in Continue Reading
Unexpected, but welcome, inclusion in Cures 2.0 of provision for real-world evidence in evaluation of safety and efficacy of pharmaceutical products. CONTEXT: The follow-up to the U.S 21st Century Cures Continue Reading
CONTEXT: Announcement from Gilead that analyses of three real-world data sets (2 US and 1 global) showed remdesivir lowered the risk of mortality in hospitalised COVID patients. The studies included Continue Reading
